和铂医药（上海）有限公司 Harbour BioMed
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non-Executive Director 2023-08-08 16:10
Nona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBio 2023-07-14 08:29
Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation 2023-07-13 18:11
Harbour BioMed Announces Biologics License Application Acceptance of Batoclimab for Treatment of Generalized Myasthenia Gravis by NMPA 2023-06-29 21:26
Nona Biosciences Appoints Steve Arkinstall, D. Phil., as Chief Scientific Advisor 2023-06-07 09:00
Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020 2023-06-05 09:01
Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart in Combination of Toripalimab in Patients with Hepatocellular Carcinoma at ASCO 2023 2023-05-29 09:42
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics 2023-05-23 13:00
Nona Biosciences Announces Strategic Collaboration Agreement with PharmaEssentia Innovation Research Center 2023-05-12 09:32
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses 2023-04-19 08:45
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio 2023-04-06 10:20
Harbour BioMed Reports Full Year 2022 Financial Results 2023-04-03 15:10
Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis 2023-03-06 14:27
Nona Biosciences Enters into HCAb Based Antibody Discovery Collaboration Agreement with Mythic Therapeutics 2023-02-10 13:00
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders 2023-01-26 09:22
Nona Biosciences Enters into HCAb Based Drug Discovery Collaboration Agreement with Dragonfly Therapeutics 2022-11-21 17:31
Nona Biosciences Announces Attendance at PEGS Europe 2022 2022-11-15 15:57
HARBOUR BIOMED LAUNCHES NONA BIOSCIENCES' "IDEAS TO IND" PRECLINICAL SOLUTIONS BUSINESS TO ACCELERATE GLOBAL BIOTHERAPEUTIC INNOVATION 2022-11-15 12:19
Harbour BioMed Enters into a License and Collaboration Agreement with Moderna 2022-11-11 09:03
Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United States 2022-10-20 16:20
1 2 3 4 5 6 7